Cellebrite Prepares to Lay Off Dozens of Employees Amid Global Restructuring
Digital intelligence firm Cellebrite plans to lay off dozens of employees globally amid a corporate reorganization, following recent leadership changes and strong third-quarter financial results.

Digital intelligence and cyber firm Cellebrite, which is traded on NASDAQ, is set to announce a round of layoffs impacting dozens of employees from its global workforce of approximately 1,200 people. The cuts are being implemented as part of a corporate reorganization to align the company's operational structure with its evolving business objectives.
The downsizing follows a period of significant leadership and strategic transition for the firm. In August, Shiven Ramji assumed the role of Chief Executive Officer, succeeding Thomas Hogan, who had held the position since August 2025. Ramji initially joined the company in May 2026 as President of Products and Technology. Concurrently, Ronen Armon, who spearheaded the products and technology organization for nearly six years, departed in July. In November, the firm announced the appointment of Rogério Ricci as Senior Vice President of Strategy and Business Development.
Strategic Realignment and Financial Growth
Beyond personnel shifts, the enterprise is undergoing major structural changes. In September, management announced plans to transfer its incorporation domicile from Israel to the USA in a move designed to strengthen its presence in the American market and broaden its investor base. The company emphasized that its ongoing operations and activities in Israel will continue without interruption.
The layoff announcement follows the release of the firm's financial results for the third quarter of 2026 last week. Cellebrite reported total revenue of $149 million, representing an 18% increase compared to the same period last year. Subscription revenue reached $134.9 million, marking a 20% gain.
Net income totaled $26.7 million, up from $20.2 million in the corresponding quarter of the previous year. Non-GAAP net income came in at $45.6 million, while adjusted EBITDA stood at $53.6 million, achieving a profitability margin of 36%. The company closed the quarter with Annual Recurring Revenue of $528.5 million, reflecting a 20% annual increase. Driven by these financial metrics, Cellebrite raised its full-year 2026 adjusted EBITDA guidance to a range of $163 million to $166 million, while projecting annual revenues between $553 million and $558 million.





